Poland market view
Poland biotech and pharma directory
Polish biotech, pharma, CDMO, and diagnostics companies — 35+ hand-reviewed profiles. Main centers: Warsaw (Polpharma, Adamed, Selvita), Krakow (Ryvu Therapeutics, Selvita HQ, Captor), Wroclaw, Gdansk. Poland combines Western-EU regulatory standards with competitive manufacturing economics.
In-depth analysis
Read the related market brief
Deep-dive editorial map of this region’s operators, capabilities, partnerships, and regulatory landscape.
Polish Biotech Landscape 2026Map of Warsaw, Krakow, Wroclaw, Gdansk biotech clusters covering Ryvu, Captor, Selvita, Molecure, Polpharma Biologics, Adamed.European AI Drug Discovery 2026Polish computational drug discovery cluster (Selvita, Ryvu, Captor, Molecure, Pure Biologics) plus the European AI biotech layer.Baltic & Polish CRO Landscape 2026CRO operators across Poland + Baltics including Selvita, Ryvu, Biomapas, Northway Biotech.
Featured records
Start with the strongest profiles
These are the best-covered records in this region and the right place to start a serious review.
Full list
Regional records
39 regional records currently match the active filter.
Regulatory filter
Quality and compliance filters
Default order keeps stronger reviewed records first. You can switch to alphabetical, country, or specialization sorting at any time.
Current review cycle
Adamed Pharma S.A.
PienkowPolandManufacturing
Integrated Polish pharmaceutical manufacturer with API and finished-dose operations, oncology, cardiology, CNS, and respiratory portfolios, and exports to more than 70 countries.
- Lead
- Piotr KoryckiPresident of the Management Board and Chief Executive Officer
- Scale
- Commercial pharmaceutical manufacturing
Current review cycle
Bioavlee S.A.
WroclawPolandDiagnostics
Wroclaw diagnostic robotics company developing AI-powered rapid bacterial identification through image-analysis microbiology for point-of-care infectious-disease diagnosis.
- Lead
- Michal K. WroneckiChief Executive Officer
- Scale
- Medical-device and AI diagnostics delivery
Current review cycle
BioResearch Pharma S.A.
WarsawPolandTherapeutics
Warsaw pharmaceutical R&D company focused on drug repositioning for dermatology, with programs in androgenetic alopecia and psoriasis and active BioInMed cluster membership.
- Lead
- Lukasz ZybaczynskiChief Executive Officer and Co-Founder
- Scale
- Drug-repositioning R&D
Current review cycle
Biotts S.A.
WroclawPolandTherapeutics
Wroclaw drug-delivery biotech with the MTC-Y Multifunctional Transdermal Carrier platform for transdermal insulin, oncology, and diabetes formulations, partnered with BIOTON.
- Lead
- Jan Henk HendriksChief Executive Officer
- Scale
- Transdermal drug-delivery R&D
Current review cycle
Diagnostyka S.A.
KrakowPolandDiagnostics
Poland's largest medical diagnostic laboratory network with 156 laboratories, over 1,100 patient collection points, and Warsaw Stock Exchange listing under the ticker DIA.
- Lead
- Jakub SwadzbaChief Executive Officer and Co-Founder
- Scale
- National clinical-diagnostic service delivery
Current review cycle
ExPLoRNA Therapeutics Sp. z o.o.
WarsawPolandBiotech
Warsaw University spin-out developing novel mRNA cap-analog technology (AvantCap, ExploCap) for mRNA therapeutics, with Gates Foundation-funded programs.
- Lead
- Jacek JemielityChief Executive Officer and Co-Founder
- Scale
- mRNA chemistry R&D
Current review cycle
Genomtec S.A.
WroclawPolandDiagnostics
Wroclaw point-of-care molecular diagnostics developer with isothermal nucleic acid amplification technology (SNAAT) for cartridge-based respiratory and infectious-disease panels, listed on Warsaw Stock Exchange.
- Lead
- Miron TokarskiChief Executive Officer and Co-Founder
- Scale
- POC diagnostic device development
Current review cycle
Hemolens Diagnostics Sp. z o.o.
WroclawPolandDiagnostics
Wroclaw medical-device software company building Cardiolens FFR-CT Pro for non-invasive cardiology diagnostics through coronary CT and blood-pressure fusion with blood-flow simulation.
- Lead
- Wojciech JezewskiChief Executive Officer
- Scale
- Medical-device software delivery
Current review cycle
Human Biome Institute S.A.
GdanskPolandTherapeutics
Gdansk microbiome biotherapeutics company operating a Microbiota Center for GMP fecal microbiota transplantation production, with Polish Medical Research Agency-funded clinical trials and biosynthetic donor-independent microbiome programs.
- Lead
- Jaroslaw BilinskiChief Executive Officer
- Scale
- GMP FMT production and clinical development
Current review cycle
intoDNA S.A.
KrakowPolandDiagnostics
Krakow molecular diagnostics biotech with the proprietary STRIDE DNA-break detection platform, supplying biomarker services for PARP inhibitors, DDR programs, and companion-diagnostic development.
- Lead
- Magda KordonChief Executive Officer and Co-Founder
- Scale
- Biomarker services operation
Current review cycle
Pikralida Sp. z o.o.
PoznanPolandTherapeutics
Poznan drug-discovery biotech (Adam Mickiewicz University spin-out) focused on neurological disorders and age-related civilizational diseases, with medicinal-chemistry and R&D collaborations.
- Lead
- Stanislaw PikulPresident and Co-Founder
- Scale
- Preclinical small-molecule development
Current review cycle
PolTREG S.A.
GdanskPolandTherapeutics
Gdansk clinical-stage cell therapy biotech developing T-regulatory cell therapies for autoimmune diseases (Type 1 diabetes, multiple sclerosis), with GMP Treg manufacturing and a Warsaw Stock Exchange listing (PTG).
- Lead
- Piotr TrzonkowskiChief Executive Officer and Co-Founder
- Scale
- GMP cell-therapy manufacturing
Current review cycle
Pure Biologics S.A.
WroclawPolandBiotech
Wroclaw antibody and aptamer discovery biotech with PureApta platform, extracorporeal apheresis therapies, and more than thirty specialist laboratories across 1,400 square meters of lab space.
- Lead
- Filip JelenChief Executive Officer and Co-Founder
- Scale
- ISO 17025 plus GMP-capable medium-scale production
Current review cycle
Synthaverse S.A.
LublinPolandManufacturing
Lublin vaccine and immunological biotherapeutics manufacturer (formerly Biomed-Lublin) producing Onko BCG for bladder cancer and Distreptaza, with Warsaw Stock Exchange listing under BML.
- Lead
- Mieczyslaw StarkowiczPresident of the Management Board and Chief Executive Officer
- Scale
- GMP vaccine manufacturing
Current review cycle
SyVento BioTech Sp. z o.o.
SkawinaPolandCDMO
Skawina GMP-capable mRNA and lipid-nanoparticle CDMO operating on a Cytiva FlexFactory platform, covering formulation, drug substance, and drug product manufacturing from preclinical to clinical stage.
- Lead
- Kajetan BartosikChief Executive Officer
- Scale
- GMP-capable mRNA and LNP manufacturing
Current review cycle
BioMaxima
LublinPolandDiagnostics
Lublin diagnostics and microbiology company producing culture media, rapid tests, and IVD products from a substantial Polish operating base.
- Lead
- Lukasz UrbanChief Executive Officer
- Scale
- Diagnostics platform
Current review cycle
Genomed
WarsawPolandGenomics
Warsaw genomics and diagnostics company providing DNA and RNA sequencing, genetic testing, and molecular diagnostics from a long-running Polish genomics platform.
- Lead
- Anna Boguszewska-ChachulskaChief Executive Officer
- Scale
- Diagnostics and genomics services platform
Current review cycle
Scope Fluidics
WarsawPolandDiagnostics
Warsaw diagnostics and microfluidics company developing rapid antimicrobial-resistance and molecular-diagnostics platforms from a Polish innovation base.
- Lead
- Piotr GarsteckiPresident of the Management Board
- Scale
- Diagnostics platform
Current review cycle
Bioton
WarsawPolandManufacturing
Warsaw-headquartered insulin and biopharmaceutical manufacturer with major Polish production operations and a strong diabetes-therapeutics footprint.
- Lead
- Jeremy LaundersCEO and President of the Management Board
- Scale
- Commercial biomanufacturing footprint
Current review cycle
Polpharma
Starogard GdanskiPolandManufacturing
Starogard Gdanski pharmaceutical manufacturing anchor and flagship Polpharma site with major production scale and sterile-capacity expansion in Poland.
- Lead
- Sebastian SzymanekPresident of the Management Board
- Scale
- Large commercial manufacturing footprint
Current review cycle
Bionanopark
ŁódźPolandCluster
Łódź science and technology park operating wet-lab, office, and commercialization infrastructure for biotech, medtech, and industrial R&D tenants.
- Lead
- Mariusz KozińskiPresident of the Management Board
- Scale
- Łódź science-park operator
Current review cycle
Jagiellonian Centre of Innovation
KrakowPolandCluster
Krakow innovation operator behind Life Science Park laboratory space, biotechnology tenancy, and startup-to-scaleup infrastructure.
- Lead
- Krzysztof KoniecznyPresident of the Management Board
- Scale
- Krakow life-science park operator
Current review cycle
Bioceltix
WroclawPolandTherapeutics
Wroclaw veterinary biologics company developing allogeneic cell therapies and regulated animal-health products.
- Lead
- Łukasz BzdzionPresident of the Management Board
- Scale
- Veterinary biologics platform
Current review cycle
Captor Therapeutics
WroclawPolandDrug discovery
Wroclaw targeted-protein-degradation company building oncology and immunology programmes around molecular glues and degrader chemistry.
- Lead
- Michał WalczakChief Executive Officer and Chief Scientific Officer
- Scale
- Precision-degradation discovery platform
Poland adds scale and a broader operating base.
The Polish layer covers biosimilars, CDMO providers, diagnostics, therapeutic companies, and manufacturing capacity that complement the Baltics.
Use this page when one standout city is not enough.
Polish records are especially useful when you need a wider company base, more city options, and stronger commercial scale than the Baltics alone can offer.
Browse by
Cities, categories, and compliance
Jump into a specific city, category, or compliance-standard page for a more focused view.
Frequently asked questions
Questions about poland biotech and pharma directory
How many biotech companies are in Poland?
The Memel Biotech directory lists 35+ verified Polish biotech, pharma, CDMO, and diagnostics companies across Warsaw, Krakow, Wroclaw, and Gdansk.
What are the main biotech cities in Poland?
Warsaw concentrates commercial and diagnostic operators (Polpharma, Adamed, Bioton); Krakow leans into research-driven biotech (Ryvu Therapeutics, Selvita); Gdansk and Wroclaw add manufacturing capacity.
What is Poland known for in biotech?
Poland has large-scale manufacturing capacity (Polpharma is one of Central Europe's largest pharma manufacturers), a growing CRO/CDMO base (Selvita), and an expanding cohort of oncology-focused therapeutic developers (Ryvu, Captor, OncoArendi).
What compliance standards do Polish biotech companies hold?
Polish companies in the directory commonly hold GMP and ISO 13485 certifications. Large manufacturing sites also carry FDA inspection markers for international supply.
Can I compare two Polish biotech companies side by side?
Yes — use the Compare button on any company card to add it to a comparison set (up to 3 companies), then open the /compare page for a side-by-side view of leadership, certifications, and operating scale.
Next step
Compare Poland with Germany and Lithuania.
Move into Germany for deeper industrial benchmarks or Lithuania for a tighter Baltic comparison.